1. Distribution of microRNA biomarker candidates in solid tissues and body fluids
    Tobias Fehlmann et al, 2016, RNA Biology CrossRef
  2. MicroRNA-455-3p functions as a tumor suppressor by targeting eIF4E in prostate cancer
    Yongxiang Zhao et al, 2017 CrossRef
  3. miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells
    Guohui Du et al, 2017 CrossRef
  4. Long-term exposure of MCF-7 breast cancer cells to ethanol stimulates oncogenic features
    Robert Gelfand et al, 2017 CrossRef
  5. MicroRNAs driving invasion and metastasis in ovarian cancer: Opportunities for translational medicine (Review)
    Carlos Palma Flores et al, 2017 CrossRef
  6. Microrna a New Gate in Cancer and Human Disease: A Review
    Ghanbar Mahmoodi Chalbatani et al, 2017, J. of Biological Sciences CrossRef
  7. Levels of MicroRNA Heterogeneity in Cancer Biology
    Nina Petrovic et al, 2017, Mol Diagn Ther CrossRef
  8. let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery
    A Spolverini et al, 2017, Oncogene CrossRef
  9. MicroRNAs as novel biomarkers for colorectal cancer: New outlooks
    Naghmeh Shirafkan et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  10. Isoliquiritigenin attenuates MiR-21 expression via induction of PIAS3 in breast cancer cells
    Shilong Ning et al, 2017, RSC Adv. CrossRef
  11. null
    Zhiguo Wang, 2018 CrossRef
  12. Function Control of Anti-microRNA Oligonucleotides Using Interstrand Cross-Linked Duplexes
    Yasuhiro Mie et al, 2018, Molecular Therapy - Nucleic Acids CrossRef
  13. Function of miR-146a-5p in Tumor Cells As a Regulatory Switch between Cell Death and Angiogenesis: Macrophage Therapy Revisited
    Elina Simanovich et al, 2018, Front. Immunol. CrossRef
  14. Hypoxia- and acidosis-driven aberrations of secreted microRNAs in endometrial cancer in vitro
    Julia Eismann et al, 2017 CrossRef
  15. Dickkopf homolog 3 (DKK3 ): A candidate for detection and treatment of cancers?
    Leila Hamzehzadeh et al, 2018, J Cell Physiol CrossRef
  16. Melatonin Inhibits the Proliferation of Gastric Cancer Cells Through Regulating the miR-16-5p-Smad3 Pathway
    Chenyu Zhu et al, 2018, DNA and Cell Biology CrossRef
  17. Dysregulation of cellular microRNAs by human oncogenic viruses – Implications for tumorigenesis
    Joana M.O. Santos et al, 2018, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
  18. Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates
    Santiago Grijalvo et al, 2018, Genes CrossRef
  19. Up-regulated MiR-27-3p promotes the G1-S phase transition by targeting inhibitor of growth family member 5 in osteosarcoma
    Pei Ye et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  20. MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.
    Lian Hui et al, 2018, Biomed Pharmacother CrossRef
  21. miRNA-mediated apoptosis activation through TMEM 48 inhibition in A549 cell line
    Feridun Akkafa et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  22. Biological role and clinical value of miR-99a-5p in head and neck squamous cell carcinoma (HNSCC): A bioinformatics-based study
    Yu-ting Chen et al, 2018, FEBS Open Bio CrossRef
  23. Comparison of the MicroRNA Expression Profiles of Male and Female Avian Primordial Germ Cell Lines
    Bence Lázár et al, 2018, Stem Cells International CrossRef
  24. Antiproliferative effect of upregulation of hsa-let-7c-5p in human acute erythroleukemia cells
    Deniz Mortazavi et al, 2018, Cytotechnology CrossRef
  25. MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA
    Hanwen Chen et al, 2018, Human Cell CrossRef
  26. Effect of dietary components on miRNA and colorectal carcinogenesis
    Adewale Oluwaseun Fadaka et al, 2018, Cancer Cell Int CrossRef
  27. Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase H
    O. A. Patutina et al, 2018, Sci Rep CrossRef
  28. An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs
    Deyu Huang et al, 2018, Food and Chemical Toxicology CrossRef
  29. NF-kappaB-inducing kinase in cancer
    Gunter Maubach et al, 2018, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  30. Niacin induces miR-502-3p expression which impairs insulin sensitivity in human adipocytes
    Emilie Montastier et al, 2018, Int J Obes CrossRef
  31. Increased serum exosomal miR-134 expression in the acute ischemic stroke patients
    Jingxia Zhou et al, 2018, BMC Neurol CrossRef
  32. The critical role of microRNAs in stress response: therapeutic prospect and limitation
    Jie Du et al, 2018, Pharmacological Research CrossRef
  33. null
    Swapan K. Ray, 2019 CrossRef
  34. Cationic Niosomes as Non-Viral Vehicles for Nucleic Acids: Challenges and Opportunities in Gene Delivery
    Santiago Grijalvo et al, 2019, Pharmaceutics CrossRef
  35. Improved Loading of Plasma-Derived Extracellular Vesicles to Encapsulate Antitumor miRNAs
    Margherita Alba Carlotta Pomatto et al, 2019, Molecular Therapy - Methods & Clinical Development CrossRef
  36. RNAi therapeutic and its innovative biotechnological evolution
    Yuhua Weng et al, 2019, Biotechnology Advances CrossRef
  37. Diversity and signature of small RNA in different bodily fluids using next generation sequencing
    Mohamed El-Mogy et al, 2018, BMC Genomics CrossRef
  38. Cryptosporidium-host Interaction Alters Regulation of OncomiRNAs and Tumor Suppressor miRNA Expression
    Feyza Basak et al, 2019, J. of Biological Sciences CrossRef
  39. Emerging drugs for primary Sjögren’s syndrome
    Saviana Gandolfo et al, 2019, Expert Opinion on Emerging Drugs CrossRef
  40. Non-coding RNAs: Regulators of glioma cell epithelial-mesenchymal transformation.
    Sheng Xin et al, 2019, Pathol Res Pract CrossRef
  41. A combined experimental and computational study on peptide nucleic acid (PNA) analogues of tumor suppressive miRNA-34a
    Valerio Piacenti et al, 2019, Bioorganic Chemistry CrossRef
  42. Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication.
    Massimo Bracci, 0 CrossRef
  43. Catalytic Knockdown of miR-21 by Artificial Ribonuclease: Biological Performance in Tumor Model
    Olga A. Patutina et al, 2019, Front. Pharmacol. CrossRef
  44. Effects of AntagomiRs on Different Lung Diseases in Human, Cellular, and Animal Models
    Giuseppe Murdaca et al, 2019, IJMS CrossRef
  45. MiR-148a inhibits the proliferation and migration of glioblastoma by targeting ITGA9
    Tong-Jiang Xu et al, 2019, Human Cell CrossRef
  46. Demonstrating specificity of bioactive peptide nucleic acids (PNAs) targeting microRNAs for practical laboratory classes of applied biochemistry and pharmacology
    Jessica Gasparello et al, 2019, PLoS ONE CrossRef
  47. A new function for miRNAs as regulators of autophagy
    Francesca Aredia et al, 2017, Future Medicinal Chemistry CrossRef
  48. Exploiting microRNAs As Cancer Therapeutics
    Tamsin Robb et al, 2017, Targ Oncol CrossRef
  49. Emerging role of SETDB1 as a therapeutic target.
    Archana Venkataramana Karanth et al, 2017, Expert Opin Ther Targets CrossRef
  50. Recent advances in understanding the role of miRNAs in exosomes and their therapeutic potential
    Xiang-yang MIAO, 2017, Journal of Integrative Agriculture CrossRef
  51. Antrodia cinnamomea sensitizes radio-/chemo-therapy of cancer stem-like cells by modulating microRNA expression
    Yu-kai Su et al, 2017, Journal of Ethnopharmacology CrossRef
  52. Assessment by miRNA microarray of an autologous cancer antigen‐pulsed adoptive immune ensemble cell therapy (AC‐ACT) approach; demonstrated induction of anti‐oncogenic and anti‐PD‐L1 miRNAs
    Masanobu Chinami et al, 2019, Clin Case Rep CrossRef
  53. Emerging role of microRNA 628-5p as a novel biomarker for cancer and other diseases
    Leslimar Rios-Colon et al, 2019, Tumour Biol. CrossRef
  54. Efficient Delivery of MicroRNA and AntimiRNA Molecules Using an Argininocalix[4]arene Macrocycle
    Jessica Gasparello et al, 2019, Molecular Therapy - Nucleic Acids CrossRef
  55. null
    Lory Santarelli et al, 2020 CrossRef
  56. Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview.
    Cristina Elena Staicu et al, 2020, Cells CrossRef
  57. null
    Yan-Hui Zhou et al, 2020 CrossRef
  58. High Levels of Apoptosis Are Induced in the Human Colon Cancer HT-29 Cell Line by Co-Administration of Sulforaphane and a Peptide Nucleic Acid Targeting miR-15b-5p
    Jessica Gasparello et al, 2020, Nucleic Acid Therapeutics CrossRef
  59. NF-κB p65 represses microRNA-124 transcription in diffuse large B-cell lymphoma
    Hyein Shim et al, 2020, Genes Genom CrossRef
  60. Anticancer properties and mechanism of action of the quassinoid ailanthone
    Christian Bailly, 2020, Phytotherapy Research CrossRef
  61. Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules
    Rafael R. Castillo et al, 2020, Pharmaceutics CrossRef
  62. Epi-drugs as triple-negative breast cancer treatment
    Mouhamed Idrissou et al, 2020, Epigenomics CrossRef
  63. Role of microRNA dysregulation in childhood acute leukemias: diagnostics, monitoring and therapeutics: A comprehensive review
    Joanna Szczepanek, 2020, WJCO CrossRef
  64. Clinical significance of miRNA‑1 and its potential target gene network in lung squamous cell carcinoma
    Xiaojiao Li et al, 2019, Mol Med Report CrossRef
  65. miR‑539 suppresses the proliferation, migration, invasion and epithelial mesenchymal transition of pancreatic cancer cells through targeting SP1.
    Liang Xue et al, 2020, Int J Mol Med CrossRef
  66. MiR‑370 promotes apoptosis in colon cancer by directly targeting MDM4
    Xiaogang Shen et al, 2017, Oncol Lett CrossRef
  67. Anticancer effect of miR-96 inhibitor in bladder cancer cell lines
    Ting Xu et al, 2018, Oncol Lett CrossRef
  68. Targeting miR‑155‑5p and miR‑221‑3p by peptide nucleic acids induces caspase‑3 activation and apoptosis in temozolomide‑resistant T98G glioma cells
    Roberta Milani et al, 2019, Int J Oncol CrossRef
  69. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review)
    Alessia Finotti et al, 2018, Int J Oncol CrossRef
  70. Multipotent miRNA Sponge-Loaded Magnetic Nanodroplets with Ultrasound/Magnet-Assisted Delivery for Hepatocellular Carcinoma Therapy
    Wei Dong et al, 2020, Mol. Pharmaceutics CrossRef
  71. Heat shock protein-27 and MiR-17-5p are novel diagnostic and prognostic biomarkers for hepatocellular carcinoma in Egyptian patients
    Nermin Raafat et al, 2020, Gene Reports CrossRef
  72. Construction of a 13‐microRNA‐based signature and prognostic nomogram for predicting overall survival in patients with hepatocellular carcinoma
    Zhihua Zheng et al, 2020, Hepatol Res CrossRef
  73. A Distinctive microRNA (miRNA) Signature in the Blood of Colorectal Cancer (CRC) Patients at Surgery.
    Jessica Gasparello et al, 2020, Cancers (Basel) CrossRef
  74. The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer
    Soyeon Kim et al, 2020 CrossRef
  75. MiR-887 Promotes the Progression of Hepatocellular Carcinoma via Targeting VHL
    Wei Zou et al, 2020, Technol Cancer Res Treat CrossRef
  76. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients
    Yusheng Huang et al, 2020, BMC Genomics CrossRef
  77. The Role of MicroRNAs in Vitiligo: Regulators and Therapeutic Targets
    Lili Li, 2020, Ann Dermatol CrossRef
  78. null
    A. Gameiro et al, 2020 CrossRef
  79. MicroRNAs at the Crossroad of the Dichotomic Pathway Cell Death vs. Stemness in Neural Somatic and Cancer Stem Cells: Implications and Therapeutic Strategies
    Andrea Diana et al, 2020, IJMS CrossRef
  80. null
    Alessia Finotti et al, 2021 CrossRef
  81. MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization
    Alexandra Neaga et al, 2021, Front. Immunol. CrossRef
  82. miRNA-128 modulates bone neoplasms cells proliferation and migration through the WNT/β-catenin and EMT signal pathways
    Yang Li et al, 2021, J Orthop Surg Res CrossRef
  83. MicroRNA-143 Sensitizes Cervical Cancer Cells to Cisplatin: a Promising Anticancer Combination Therapy
    Yalda Baghay Esfandyari et al, 2021, Reprod. Sci. CrossRef
  84. Label free detection of miRNA-21 with Electrolyte Gated Organic Field Effect Transistors (EGOFETs)
    Meenu Selvaraj et al, 2021, Biosensors and Bioelectronics CrossRef
  85. Ligand decorated biodegradable nanomedicine in the treatment of cancer
    Ejaj Ahmad et al, 2021, Pharmacological Research CrossRef
  86. The potential of miRNA-based therapeutics in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection: a review
    Leonny Dwi Rizkita et al, 2021, Journal of Pharmaceutical Analysis CrossRef
  87. miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma
    Giovanni Zarrilli et al, 2021, IJMS CrossRef
  88. Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview.
    Maja Sabol, 0 CrossRef
  89. The Role of miR-640: A Potential Suppressor in Breast Cancer via Wnt7b/β-catenin Signaling Pathway
    Chun Tang et al, 2021, Front. Oncol. CrossRef
  90. MicroRNAs in Metastasis and the Tumour Microenvironment
    Carla Solé et al, 2021, IJMS CrossRef
  91. Small Noncoding RNAs in Knee Osteoarthritis: The Role of MicroRNAs and tRNA-Derived Fragments.
    Julian Zacharjasz et al, 2021, Int J Mol Sci CrossRef
  92. MicroRNA-17-5p inhibits thyroid cancer progression by suppressing Early growth response 2 (EGR2).
    Xiang Geng et al, 2021, Bioengineered CrossRef
  93. Enzymatic Spermine Metabolites Induce Apoptosis Associated with Increase of p53, caspase-3 and miR-34a in Both Neuroblastoma Cells, SJNKP and the N-Myc-Amplified Form IMR5
    Yuta Kanamori et al, 2021, Cells CrossRef
  94. The prognostic significance of microRNA-221 in hepatocellular carcinoma: An updated meta-analysis
    Wenfeng Liu et al, 2021, Int J Biol Markers CrossRef
  95. MicroRNAs Patterns as Potential Tools for Diagnostic and Prognostic Follow-Up in Cancer Survivorship
    Ilaria Conti et al, 2021, Cells CrossRef
  96. Methylation‐associated silencing of miR‐9‐1 promotes nasopharyngeal carcinoma progression and glycolysis via HK2
    Qian‐Lan Xu et al, 2021, Cancer Sci CrossRef
  97. MicroRNA as an Important Target for Anticancer Drug Development
    Zhiwen Fu et al, 2021, Front. Pharmacol. CrossRef
  98. Shifting Gears in Precision Oncology—Challenges and Opportunities of Integrative Data Analysis
    Ka-Won Noh et al, 2021, Biomolecules CrossRef
  99. Pan-Cancer Analysis Reveals Common and Specific Relationships between Intragenic miRNAs and Their Host Genes
    Baohong Liu et al, 2021, Biomedicines CrossRef
  100. Regulatory interplay between microRNAs and WNT pathway in glioma
    Peyman Tabnak et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  101. Gene therapy: A promising approach for breast cancer treatment
    Niloufar Tavakoli Dastjerd et al, 2021, Cell Biochem Funct CrossRef
  102. Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups
    Emilia Bevacqua et al, 2021, Cancers CrossRef
  103. Iodine-125 seed represses the growth and facilitates the apoptosis of colorectal cancer cells by suppressing the methylation of miR-615 promoter
    Fenghai Ren et al, 2022, BMC Cancer CrossRef
  104. Exosome-derived noncoding RNAs: Function, mechanism, and application in tumor angiogenesis
    Kangkang Yang et al, 2022, Molecular Therapy - Nucleic Acids CrossRef
  105. The Roles of microRNAs in Cancer Multidrug Resistance
    Lucia Pavlíková et al, 2022, Cancers CrossRef
  106. Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in prostate cancer: Current status and future perspectives
    Ahmad Movahedpour et al, 2019, J of Cellular Biochemistry CrossRef
  107. null
    Kevin Holm et al, 2022 CrossRef
  108. MiR-26a-5p as a useful therapeutic target for upper tract urothelial carcinoma by regulating WNT5A/β-catenin signaling
    Yueh-Hua Chung et al, 2022, Sci Rep CrossRef
  109. miR-34a Enhances the Susceptibility of Gastric Cancer to Platycodin D by Targeting Survivin
    Yao Peng et al, 2019, Pathobiology CrossRef
  110. The New Face of a Well-Known Antibiotic: A Review of the Anticancer Activity of Enoxacin and Its Derivatives
    Karolina Jałbrzykowska et al, 2022, Cancers CrossRef
  111. Urinary microRNAs and Their Significance in Prostate Cancer Diagnosis: A 5-Year Update
    Jaroslav Juracek et al, 2022, Cancers CrossRef
  112. DNA–Liposome Hybrid Carriers for Triggered Cargo Release
    Kevin N. Baumann et al, 2022, ACS Appl. Bio Mater. CrossRef
  113. MicroRNAs and Their Big Therapeutic Impacts: Delivery Strategies for Cancer Intervention
    Charles Holjencin et al, 2022, Cells CrossRef
  114. null
    Zhiguo Wang et al, 2022 CrossRef
  115. miRacle of microRNA-Driven Cancer Nanotherapeutics
    Goknur Kara et al, 2022, Cancers CrossRef
  116. miRNA nanoencapsulation to regulate the programming of the blood-brain barrier permeability BY hypoxia
    Esteban G. Figueroa et al, 2022, Current Research in Pharmacology and Drug Discovery CrossRef
  117. Modulatory role of miRNAs in thyroid and breast cancer progression and insights into their therapeutic manipulation
    Rubai Ahmed et al, 2022, Current Research in Pharmacology and Drug Discovery CrossRef
  118. Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review
    Suhail Ahmad Mir et al, 2022, Molecules CrossRef
  119. Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target
    Amir Yarahmadi et al, 2022, Molecular & Cellular Oncology CrossRef
  120. Integrated analyses identify miR‐34c‐3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma
    Qiaoyou Weng et al, 2020, The FASEB Journal CrossRef
  121. null
    Neetika Nath et al, 2022 CrossRef
  122. Identification of potential microRNA diagnostic panels and uncovering regulatory mechanisms in breast cancer pathogenesis
    Zahra Sharifi et al, 2022, Sci Rep CrossRef
  123. Prognostic value of microRNAs in patients with small cell lung cancer: a meta-analysis
    Jun Peng et al, 2022, World J Surg Onc CrossRef
  124. null
    Bineypreet Kaur et al, 2023 CrossRef
  125. MiR-6165 Dysregulation in Breast Cancer and Its Effect on Cell Proliferation and Migration
    Seyed Omar Ebrahimi et al, 2021, Iran South Med J CrossRef
  126. null
    A. L. Malinowska et al, 2019 CrossRef
  127. MicroRNA-155 and Disease-Related Immunohistochemical Parameters in Cutaneous Melanoma
    Manal S. Fawzy et al, 2023, Diagnostics CrossRef
  128. Combined Treatment of Cancer Cells Using Allyl Palladium Complexes Bearing Purine-Based NHC Ligands and Molecules Targeting MicroRNAs miR-221-3p and miR-222-3p: Synergistic Effects on Apoptosis
    Chiara Tupini et al, 2023, Pharmaceutics CrossRef
  129. Hippo-YAP/TAZ signaling in breast cancer: Reciprocal regulation of microRNAs and implications in precision medicine
    Farzad Sadri et al, 2023, Genes & Diseases CrossRef
  130. The key role of microRNA-766 in the cancer development
    Jitendra Gupta et al, 2023, Front. Oncol. CrossRef
  131. Circular RNA AGAP1 Stimulates Immune Escape and Distant Metastasis in Renal Cell Carcinoma
    ChangGuo Du et al, 2023, Mol Biotechnol CrossRef
  132. Angiogenesis and Prostate cancer: microRNAs comes into view
    Jitendra Gupta et al, 2023, Pathology - Research and Practice CrossRef
  133. Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
    Bashdar Mahmud Hussen et al, 2023, Military Med Res CrossRef
  134. Shear stress and microRNAs for better metastatic cancer management
    Siluveru KrishnaPriya et al, 2023, Biotechnology Progress CrossRef
  135. null
    Aliakbar Yousefi-Ahmadipour et al, 2024 CrossRef
  136. Vitamin D and microRNAs: Role in the pathogenesis and prognosis of breast cancer (Review)
    Luca Falzone et al, 2023, Int J Epigen CrossRef
  137. Engineered mesoporous silica nanoparticles, new insight nanoplatforms into effective cancer gene therapy
    Razieh Heidari et al, 2023, International Journal of Biological Macromolecules CrossRef
  138. Exploring signaling pathway crosstalk in glioma by mapping miRNA and WNT pathways: A review
    Adamu Imam Isa, 2023, International Journal of Biological Macromolecules CrossRef
  139. Expression of MicroRNA-200a/b/c in the Mediobasal Hypothalamic Nuclei with Aging
    Valentina V. Porseva et al, 2023, MIRNA CrossRef
  140. Bioengineered chimeric tRNA/pre‐miRNAs as prodrugs in cancer therapy
    Fatemeh Rafieenia et al, 2023, Biotechnology Progress CrossRef
  141. Drug regulation of microRNA
    A.E. Abaturov et al, 2024, CH CrossRef
  142. Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapy
    Kenneth K.W. To et al, 2024, Drug Resistance Updates CrossRef
  143. Regulation of sirt1 and foxo1 in glucose metabolism of Megalobrama amblycephala
    Qiaoqiao Mu et al, 2024, Gene CrossRef
  144. Circular RNA COL1A1 promotes Warburg effect and tumor growth in nasopharyngeal carcinoma
    ZeJun Zhou et al, 2024, Discov Onc CrossRef